Cargando…

Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential

Immunotherapy, including immunostimulation and immunosuppression, has seen significant development in the last 10 years. Immunostimulation has been verified as effective in anti-cancer treatment, while immunosuppression is used in the treatment of autoimmune disease and inflammation. Currently, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Jing, Creaven, Dale, Luan, Xiangshu, Wang, Jiemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353199/
https://www.ncbi.nlm.nih.gov/pubmed/37461033
http://dx.doi.org/10.1186/s12967-023-04342-w
_version_ 1785074668644859904
author Wen, Jing
Creaven, Dale
Luan, Xiangshu
Wang, Jiemin
author_facet Wen, Jing
Creaven, Dale
Luan, Xiangshu
Wang, Jiemin
author_sort Wen, Jing
collection PubMed
description Immunotherapy, including immunostimulation and immunosuppression, has seen significant development in the last 10 years. Immunostimulation has been verified as effective in anti-cancer treatment, while immunosuppression is used in the treatment of autoimmune disease and inflammation. Currently, with the update of newly-invented simplified isolation methods and the findings of potent triggered immune responses, extracellular vesicle-based immunotherapy is very eye-catching. However, the research on three main types of extracellular vesicles, exosomes, microvesicles and apoptotic bodies, needs to be more balanced. These three subtypes share a certain level of similarity, and at the same time, they have their own properties caused by the different methods of biogensis. Herein, we summarized respectively the status of immunotherapy based on each kind of vesicle and discuss the possible involved mechanisms. In conclusion, we highlighted that the effect of the apoptotic body is clear and strong. Apoptotic bodies have an excellent potential in immunosuppressive and anti-inflammatory therapies .
format Online
Article
Text
id pubmed-10353199
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103531992023-07-19 Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential Wen, Jing Creaven, Dale Luan, Xiangshu Wang, Jiemin J Transl Med Review Immunotherapy, including immunostimulation and immunosuppression, has seen significant development in the last 10 years. Immunostimulation has been verified as effective in anti-cancer treatment, while immunosuppression is used in the treatment of autoimmune disease and inflammation. Currently, with the update of newly-invented simplified isolation methods and the findings of potent triggered immune responses, extracellular vesicle-based immunotherapy is very eye-catching. However, the research on three main types of extracellular vesicles, exosomes, microvesicles and apoptotic bodies, needs to be more balanced. These three subtypes share a certain level of similarity, and at the same time, they have their own properties caused by the different methods of biogensis. Herein, we summarized respectively the status of immunotherapy based on each kind of vesicle and discuss the possible involved mechanisms. In conclusion, we highlighted that the effect of the apoptotic body is clear and strong. Apoptotic bodies have an excellent potential in immunosuppressive and anti-inflammatory therapies . BioMed Central 2023-07-17 /pmc/articles/PMC10353199/ /pubmed/37461033 http://dx.doi.org/10.1186/s12967-023-04342-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Wen, Jing
Creaven, Dale
Luan, Xiangshu
Wang, Jiemin
Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_full Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_fullStr Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_full_unstemmed Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_short Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_sort comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353199/
https://www.ncbi.nlm.nih.gov/pubmed/37461033
http://dx.doi.org/10.1186/s12967-023-04342-w
work_keys_str_mv AT wenjing comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential
AT creavendale comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential
AT luanxiangshu comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential
AT wangjiemin comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential